Document is current

Any future updates will be listed below

Engineering CAR-expressing natural killer cells with cytokine signaling and synthetic switch for an off-the-shelf cell-based cancer immunotherapy

Crossref DOI link: https://doi.org/10.1557/mrc.2019.31

Published Online: 2019-06-20

Published Print: 2019-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark